Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07118618 · ClinicalTrials.gov registry record · Phase 2
Probenecid Administration for Alcohol Craving and Consumption
A Phase 2 study of Alcohol Use Disorder (AUD) and Alcohol Consumption, sponsored by Brown University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07118618 is a Phase 2 study of Alcohol Use Disorder (AUD) and Alcohol Consumption that is actively recruiting participants, run by Brown University. The registered enrollment target is 120 participants, below the 1,820-participant average among 30 other Alcohol Use Disorder (AUD) trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07118618, a Phase 2 study of Alcohol Use Disorder (AUD) and Alcohol Consumption, is actively recruiting participants, sponsored by Brown University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study proposes a 16-week, between-subject, double-blind, randomized controlled trial (RCT) with probenecid (2g /day) compared to placebo in individuals with AUD to test if reduces craving and alcohol consumption.
Conditions Studied
Interventions
- DRUG Placebo Oral Tablet
- DRUG Probenecid Oral Tablet
Study Locations (1)
Rhode Island
- Brown University - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-03-14 |
| Est. Completion | 2030-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07118618
The ClinicalTrials.gov registry entry for NCT07118618 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,820-participant average among 30 other Alcohol Use Disorder (AUD) trials with a reported enrollment target (93% lower). The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Alcohol Use Disorder (AUD) appearing as the primary indexed condition, and to 2 interventions - of which Placebo Oral Tablet is the first listed.
NCT07118618 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT07118618 about?
NCT07118618 is a clinical study titled "Probenecid Administration for Alcohol Craving and Consumption". This study proposes a 16-week, between-subject, double-blind, randomized controlled trial (RCT) with probenecid (2g /day) compared to placebo in individuals with AUD to test if reduces craving and alcohol consumption.
What is the current status of trial NCT07118618?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2026-03-14. Estimated completion is 2030-12-31.
What conditions does trial NCT07118618 study?
This clinical trial studies the following conditions: Alcohol Use Disorder (AUD), Alcohol Consumption, Craving.
What interventions are being tested in trial NCT07118618?
The interventions under investigation include: Placebo Oral Tablet (DRUG), Probenecid Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT07118618?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07118618 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder (AUD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
RECRUITING · Phase 2
-
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
RECRUITING · Phase 2
-
Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)
RECRUITING · Phase 2
-
Study of Tirzepatide for Recovery and Alcohol Use Management
RECRUITING · Phase 2
-
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
RECRUITING · Phase 2
-
Suvorexant for Treatment of AUD and PTSD
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.